Long-Term Synaptic Depression: Clinical Trials

13 trials of Long-Term Synaptic Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 1 unknown. 13 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 12, Unknown 1
Phase 23Completed 3

Follow Long-Term Synaptic Depression: new trials by email Literature Review of Long-Term Synaptic Depression trials Research Report on Long-Term Synaptic Depression

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Iron Sucrose Injection in Healthy Participants
Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues
Phase 1CompletedSichuan Huiyu Pharmaceutical Co., Ltd482024-11-222025-03-24
Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects
Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer), Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) - Bioequivalency, Safety Issues
Phase 1CompletedSichuan Huiyu Pharmaceutical Co., Ltd482024-06-252024-10-08
Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body
Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd. - Bioequivalence, Schizophrenia
Phase 1UnknownThe Affiliated Hospital of Qingdao University1002023-09-202023-10-04
Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects
Meloxicam Nanocrystal Injection(Yangtze River Pharmaceutical Group Co., Ltd.), Meloxicam Nanocrystal Injection (ANJESO®) - Pain
Phase 1CompletedYangtze River Pharmaceutical Group Co., Ltd.202023-07-052026-06-29
A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State
Senaparib 10 mg strength capsules manufactured by WuXi STA (Wuxi) Co., Ltd., Senaparib 10 mg strength capsules manufactured by WuXi STA (Shanghai) Co., Ltd. - Solid Tumor
Phase 1CompletedImpact Therapeutics, Inc.322021-07-182025-06-22
Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS
recombinant human growth hormone, Saline - Phelan-McDermid Syndrome, Growth Hormone Treatment
Phase 1 / Phase 2CompletedAffiliated Hospital of Jiangnan University62020-06-142022-10-10
Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity
Midazolam, Ketoconazole, Rifampicin - Healthy
Phase 1CompletedSeoul National University Hospital162012-12-012014-05-26
A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
3.50±0.25logCCID50/ml, 4.25±0.25 logCCID50/ml, 5.00±0.25 logCCID50/ml - Mumps
Phase 1CompletedInstitute of Medical Biology, Chinese Academy of Medical Sciences3002012-10-012023-10-10
PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg
Test-Bepotastine salicylate 9.64 mg, Reference-bepotastine besilate 10 mg - Allergic Rhinitis, Urticaria
Phase 1CompletedKorea University Anam Hospital262011-04-012013-07-12
Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke
Dl-3-n-butylphthalide, Cerebrolysin, Placebo - Acute Cerebral Stroke Within 12 Hours for the First Time
Phase 1 / Phase 2CompletedShanghai 6th People's Hospital842010-01-012020-08-24
Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China
S-1, leucovorin, oxaliplatin - Colorectal Cancer
Phase 1 / Phase 2CompletedShen Lin202009-09-012015-05-19
Pharmacokinetic Comparisons of Two Donepezil Formulations
Donepezil, ODT 10 mg, Donepezil, 10 mg tablet - Alzheimer Disease
Phase 1CompletedKorea University Anam Hospital222008-01-012011-02-16
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
Cilostazol 50 mg Tablets (Eon Pharma, LLC, USA), Pletal (Cilostazol) 50 mg Tablets (Otsuka Pharma Co, Ltd., USA) - Pain
Phase 1CompletedSandoz262004-01-012017-03-28

Conditions studied

Pain (2)  ·  Alzheimer Disease (1)  ·  Colorectal Neoplasms (1)  ·  Ischemic Stroke (1)  ·  Mumps (1)  ·  Pruritus (1)  ·  Rhinitis, Allergic (1)  ·  Schizophrenia (1)  ·  Telomeric 22q13 Monosomy Syndrome (1)  ·  Urticaria (1)

Sponsors

Korea University Anam Hospital (2)  ·  Sichuan Huiyu Pharmaceutical Co., Ltd (2)  ·  Affiliated Hospital of Jiangnan University (1)  ·  Impact Therapeutics, Inc. (1)  ·  Institute of Medical Biology, Chinese Academy of Medical Sciences (1)  ·  Sandoz (1)  ·  Seoul National University Hospital (1)  ·  Shanghai 6th People's Hospital (1)  ·  Shen Lin (1)  ·  The Affiliated Hospital of Qingdao University (1)  ·  Yangtze River Pharmaceutical Group Co., Ltd. (1)

Countries

China (9)  ·  South Korea (3)

Top investigators

Chuanling Li (1)  ·  Chun Wan (1)  ·  Gaetano Morelli, M.D. (1)  ·  Ji-Young Park, MD, PhD (1)  ·  Joo-Youn Cho, PhD (1)  ·  Lixia Xue, M.D., Ph.D. (1)  ·  YueYing Liu, Phd (1)  ·  Yuliang Zhao, Master (1)

Results publications

PMID 21723605, PMID 24105252, PMID 24614759, PMID 26158159, PMID 27168844, PMID 27317471